Home › Funds › Sofinnova Investments, Inc. › GMED
Sofinnova Investments, Inc. position in GMED
GLOBUS MED INC · Health Care
Sofinnova Investments, Inc. reported holding 200,000 shares of GMED (GLOBUS MED INC) in its Q2 2026 13F filing — a position valued at US$15.8M, representing 0.84% of its reported portfolio and ranking #31 among its reported holdings. Sofinnova Investments, Inc. has disclosed GMED holdings in 2 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Sofinnova Investments, Inc.'s GMED position evolved
Sofinnova Investments, Inc. first disclosed a stake in GMED in Q4 2024 at 244,700 shares (US$20.2M). Across 2 filings, Sofinnova Investments, Inc. held the position steady without any share-count change. The most recent filing (Q2 2026) shows 200,000 shares valued at US$15.8M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 244.70K | $20.24M | New |
| Q2 2026 | 200.00K | $15.80M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GMED and 13F data
GMED (GLOBUS MED INC) is a Health Care company. 39 other funds we track also report a position in GMED — the largest reported positions include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (US$338.1M), Sculptor Capital LP (US$237.0M), Boston Trust Walden Corp (US$124.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GMED
- KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 4.28M sh · $338.14M · Q2 2026
- Sculptor Capital LP 3.00M sh · $237.03M · Q2 2026
- Boston Trust Walden Corp 1.57M sh · $124.31M · Q2 2026
- GW&K Investment Management, LLC 1.45M sh · $114.82M · Q2 2026
- GENEVA CAPITAL MANAGEMENT LLC 1.42M sh · $111.96M · Q2 2026
- Madison Avenue Partners, LP 935.22K sh · $73.89M · Q2 2026
- ANTIPODES PARTNERS Ltd 905.98K sh · $71.58M · Q2 2026
- PARADIGM CAPITAL MANAGEMENT INC/NY 886.50K sh · $70.04M · Q2 2026
More on Sofinnova Investments, Inc.
FAQ
How long has Sofinnova Investments, Inc. held GMED?
Sofinnova Investments, Inc. has disclosed GMED holdings in 2 of the last 7 reported quarters, going back to Q4 2024.
What is Sofinnova Investments, Inc.'s current position in GMED?
As of Q2 2026, Sofinnova Investments, Inc. holds 200.00K shares of GMED (GLOBUS MED INC), valued at $15.80M, representing 0.84% of its reported portfolio and ranking #31.
Has Sofinnova Investments, Inc. been buying or selling GMED?
In the latest 13F filing (Q2 2026), Sofinnova Investments, Inc. newly opened its position in GMED.
Which other funds hold GMED?
Other major institutional holders of GMED include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, Sculptor Capital LP, Boston Trust Walden Corp, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.